{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:05:53Z","timestamp":1773281153992,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10792-016-0219-2","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T11:51:57Z","timestamp":1457697117000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of dexamethasone intravitreal implant for the treatment of persistent diffuse diabetic macular edema"],"prefix":"10.1007","volume":"37","author":[{"given":"Ebru","family":"Esen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selcuk","family":"Sizmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihal","family":"Demircan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"key":"219_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.survophthal.2008.10.001","volume":"54","author":"N Bhagat","year":"2009","unstructured":"Bhagat N, Grigorian RA, Tutela A, Zarbin MA (2009) Diabetic macular edema: pathogenesis and treatment. Surv Ophthalmol 54:1\u201332","journal-title":"Surv Ophthalmol"},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ophtha.2008.09.037","volume":"116","author":"H Funatsu","year":"2009","unstructured":"Funatsu H, Noma H, Mimura T, Eguchi S, Hori S (2009) Association of vitreous inflammatory factors with diabetic macular edema. Ophthalmology 116:73\u201379","journal-title":"Ophthalmology"},{"key":"219_CR3","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2147\/OPTH.S48364","volume":"7","author":"E Pacella","year":"2013","unstructured":"Pacella E, Vestri AR, Muscella R, Carbotti MR, Castellucci M, Coi L et al (2013) Preliminary results of an intravitreal dexamethasone implant (Ozurdex\u00ae) in patients with persistent diabetic macular edema. Clin Ophthalmol 7:1423\u20131428","journal-title":"Clin Ophthalmol"},{"key":"219_CR4","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1016\/j.ophtha.2012.07.058","volume":"119","author":"AC Ho","year":"2012","unstructured":"Ho AC, Scott IU, Kim SJ, Brown GC, Brown MM, Ip MS, Recchia FM (2012) Anti-vascular endothelial growth factor pharmacotherapy for diabetic macular edema: a report by the American Academy of Ophthalmology. Ophthalmology 119:2179\u20132188","journal-title":"Ophthalmology"},{"key":"219_CR5","first-page":"CD005656","volume":"1","author":"D Grover","year":"2008","unstructured":"Grover D, Li TJ, Chong CC (2008) Intravitreal steroids for macular edema in diabetes. Cochrane Database Syst Rev 1:CD005656","journal-title":"Cochrane Database Syst Rev"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000362764","volume":"52","author":"F Bandello","year":"2014","unstructured":"Bandello F, Preziosa C, Querques G, Lattanzio R (2014) Update of intravitreal steroids for the treatment of diabetic macular edema. Ophthalmic Res 52:89\u201396","journal-title":"Ophthalmic Res"},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1177\/112067210601600411","volume":"16","author":"JB Jonas","year":"2006","unstructured":"Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B (2006) Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema. Eur J Ophthalmol 16:566\u2013672","journal-title":"Eur J Ophthalmol"},{"key":"219_CR8","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ophtha.2006.02.065","volume":"113","author":"MC Gillies","year":"2006","unstructured":"Gillies MC, Sutter FK, Simpson JM et al (2006) Intravitreal triamcinolone for refractory diabetic macular edema two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533\u20131538","journal-title":"Ophthalmology"},{"key":"219_CR9","first-page":"139","volume":"5","author":"Cardillo JA Herrero-Vanrell","year":"2011","unstructured":"Herrero-Vanrell Cardillo JA, Kuppermann BD (2011) Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema. Clin Ophthalmol 5:139\u2013146","journal-title":"Clin Ophthalmol"},{"key":"219_CR10","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","volume":"121","author":"DS Boyer","year":"2014","unstructured":"Boyer DS, Yoon YH, Belfort R Jr et al (2014) Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema. Ophthalmology 121:1904\u20131914","journal-title":"Ophthalmology"},{"key":"219_CR11","first-page":"CD007419","volume":"10","author":"G Virgili","year":"2014","unstructured":"Virgili G, Parravano M, Menchini F, Evans JR (2014) Anti-vascular endothelial growth factor for diabetic macular oedema. Cochrane Database Syst Rev 10:CD007419","journal-title":"Cochrane Database Syst Rev"},{"key":"219_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2015.04.015","volume":"22","author":"Y Totan","year":"2015","unstructured":"Totan Y, G\u00fcler E, G\u00fcra\u011fa\u00e7 FB (2015) Dexamethasone intravitreal implant for chronic diabetic macular edema resistant to intravitreal bevacizumab treatment. Curr Eye Res 22:1\u20137","journal-title":"Curr Eye Res"},{"key":"219_CR13","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/IAE.0b013e3182a48958","volume":"34","author":"R Lazic","year":"2014","unstructured":"Lazic R, Lukic M, Boras I et al (2014) Treatment of anti-vascular endothelial growth factor-resistant diabetic macular edema with dexamethasone intravitreal implant. Retina 34:719\u2013724","journal-title":"Retina"},{"key":"219_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000356413","volume":"231","author":"M Dutra Medeiros","year":"2014","unstructured":"Dutra Medeiros M, Postorino M, Navarro R, Garcia-Arum\u00ed J, Mateo C, Corc\u00f3stegui B (2014) Dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema. Ophthalmologica 231:141\u2013146","journal-title":"Ophthalmologica"},{"key":"219_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0974-620X.99368","volume":"5","author":"P Rishi","year":"2012","unstructured":"Rishi P, Rishi E, Kuniyal L, Mathur G (2012) Short-term results of intravitreal dexamethasone implant (OZURDEX(\u00ae)) in treatment of recalcitrant diabetic macular edema: a case series. Oman J Ophthalmol 5:79\u201382","journal-title":"Oman J Ophthalmol"},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000336225","volume":"228","author":"I Zucchiatti","year":"2012","unstructured":"Zucchiatti I, Lattanzio R, Querques G et al (2012) Intravitreal dexamethasone implant in patients with persistent diabetic macular edema. Ophthalmologica 228:117\u2013122","journal-title":"Ophthalmologica"},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"364143","DOI":"10.1155\/2014\/364143","volume":"2014","author":"D Zalewski","year":"2014","unstructured":"Zalewski D, Raczy\u0144ska D, Raczy\u0144ska K (2014) Five-month observation of persistent diabetic macular edema after intravitreal injection of Ozurdex implant. Mediators Inflamm 2014:364143","journal-title":"Mediators Inflamm"},{"key":"219_CR18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/IAE.0000000000000443","volume":"35","author":"M Scaramuzzi","year":"2015","unstructured":"Scaramuzzi M, Querques G, Spina C, Lattanzio R, Bandello F (2015) Repeated intravitreal dexamethasone implant (Ozurdex) for diabetic macular edema. Retina 35:1216\u20131222","journal-title":"Retina"},{"key":"219_CR19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000371770","volume":"233","author":"JJ Escobar-Barranco","year":"2015","unstructured":"Escobar-Barranco JJ, Pina-Mar\u00edn B, Fern\u00e1ndez-Bonet M (2015) Dexamethasone implants in patients with na\u00efve or refractory diffuse diabetic macular edema. Ophthalmologica 233:176\u2013185","journal-title":"Ophthalmologica"},{"key":"219_CR20","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1167\/iovs.04-0905","volume":"46","author":"H Tamura","year":"2005","unstructured":"Tamura H, Miyamoto K, Kiryu J et al (2005) Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina. Invest Ophthalmol Vis Sci 46:1440\u20131444","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"219_CR21","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1165\/ajrcmb.16.4.9115750","volume":"16","author":"M Nauck","year":"1997","unstructured":"Nauck M, Roth M, Tamm M et al (1997) Induction of vascular endothelial growth factor by platelet-activating factor and platelet-derived growth factor is downregulated by corticosteroids. Am J Respir Cell Mol Biol 16:398\u2013406","journal-title":"Am J Respir Cell Mol Biol"},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ophtha.2007.03.057","volume":"114","author":"DJ Browning","year":"2007","unstructured":"Diabetic Retinopathy Clinical Research Network, Browning DJ, Glassman AR et al (2007) Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114:525\u2013536","journal-title":"Ophthalmology"},{"key":"219_CR23","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","volume":"117","author":"JA Haller","year":"2010","unstructured":"Haller JA, Bandello F, Belfort R Jr et al (2010) Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology 117:1134\u20131146","journal-title":"Ophthalmology"},{"key":"219_CR24","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000581","author":"S Bonnin","year":"2015","unstructured":"Bonnin S, Dupas B, Sanharawi ME et al (2015) Efficacy of dexamethasone intravitreal implant for the treatment of diabetic macular edema. Eur J Ophthalmol. doi: 10.5301\/ejo.5000581","journal-title":"Eur J Ophthalmol"},{"key":"219_CR25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5301\/ejo.5000563","volume":"25","author":"G Panozzo","year":"2015","unstructured":"Panozzo G, Gusson E, Panozzo G, Mura GD (2015) Dexamethasone intravitreal implant for diabetic macular edema: indications for a PRN regimen of treatment. Eur J Ophthalmol 25:347\u2013351","journal-title":"Eur J Ophthalmol"},{"key":"219_CR26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000371456","volume":"233","author":"M Ar\u0131kan Yorgun","year":"2015","unstructured":"Ar\u0131kan Yorgun M, Toklu Y (2015) Comment on the article by Dutra Medeiros et al. entitled \u2018dexamethasone intravitreal implant for treatment of patients with persistent diabetic macular edema\u2019. Ophthalmologica 233:117\u2013118","journal-title":"Ophthalmologica"},{"key":"219_CR27","first-page":"e121","volume":"164","author":"E Pacella","year":"2013","unstructured":"Pacella E, La Torre G, Impallara D et al (2013) Efficacy and safety of the intravitreal treatment of diabetic macular edema with pegaptanib: a 12-month follow-up. Clin Ter 164:e121\u2013e126","journal-title":"Clin Ter"},{"key":"219_CR28","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/IAE.0b013e318176de48","volume":"28","author":"D Kook","year":"2008","unstructured":"Kook D, Wolf A, Kreutzer T et al (2008) Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina 28:1053\u20131060","journal-title":"Retina"},{"key":"219_CR29","first-page":"164","volume":"1","author":"E Pacella","year":"2014","unstructured":"Pacella E, La Torre G, Turchetti P et al (2014) Evaluation of efficacy dexamethasone intravitreal implant compared to treatment with anti-VEGF in the treatment of diabetic macular edema. Senses Sci 1:164\u2013168","journal-title":"Senses Sci"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-016-0219-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0219-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-016-0219-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T12:53:37Z","timestamp":1567688017000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-016-0219-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s10792-016-0219-2","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]}}}